Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025

Case Report: Polymyxin E-associated reversible leukopenia.

View Full Paper
Ask AI
Bookmark
Share

Authors

SWSuxin WanJZJiaquan ZhuLWLihua Wang

Discussion

Loading...

Member takes

Overview

Case report reveals polymyxin E may lead to leukopenia, suggesting need for white blood cell monitoring.

Key Points

  • Polymyxin E therapy resulted in significant leukopenia, with WBC counts dropping to 0.91×10^9/L.
  • Leukopenia resolved upon stopping polymyxin E treatment, indicating a probable drug-related side effect.
  • Naranjo scale scored 7 for polymyxin E's association with leukopenia, confirming strong causality.
  • Monitoring WBC counts during polymyxin E therapy is critical for early detection of hematologic abnormalities.

Cite This Study

Wan et al. (2025) studied this question.

synapsesocial.com/papers/68c23b8fb210217d6478520chttps://doi.org/10.3389/fimmu.2025.1537972
View Full Paper
Ask AI
Bookmark
Share